Nasdaq · Healthcare
ICF International, Inc. (ICFI)
As-reported financials and recent SEC filings for ICF International, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.87B
Net income
$91.6M
Net margin
4.9%
Diluted EPS
$4.95
ROE
8.9%
P/E (TTM)
15.4×
Market cap
$1.29B
Debt / equity
0.4×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.87B | $2.02B | $1.96B | $1.78B | $1.55B |
| Gross profit | $696.0M | $737.8M | $698.2M | $645.5M | $573.5M |
| Operating income | $145.5M | $165.8M | $132.3M | $108.8M | $110.9M |
| Net income | $91.6M | $110.2M | $82.6M | $64.2M | $71.1M |
| Diluted EPS | $4.95 | $5.82 | $4.35 | $3.38 | $3.72 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-25
View on EDGAR →8-K2026-06-24
View on EDGAR →S-82026-06-22
View on EDGAR →8-K2026-06-05
View on EDGAR →42026-05-18
View on EDGAR →10-Q2026-05-07
View on EDGAR →8-K2026-05-07
View on EDGAR →SCHEDULE 13G2026-04-30
View on EDGAR →Go deeper on ICFI
Search ICF International, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.